FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmacology and represents a drug preparation for treating respiratory diseases for simultaneous, sequential or separate inhalation introduction containing crystalline monteleukast in the form of an acid and mometasone.
EFFECT: invention provides extended range of the combined drug preparations for treating respiratory diseases in the form of inhalation.
7 cl, 5 ex, 17 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
DRY INHALATION POWDER | 1999 |
|
RU2221552C2 |
COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385156C2 |
COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385721C2 |
DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING | 2014 |
|
RU2698331C2 |
INHALATION PHARMACEUTICAL COMPOSITIONS | 2013 |
|
RU2697862C2 |
NOVEL CARRIER PARTICLES FOR DRY POWDER INHALATION FORMULATIONS | 2020 |
|
RU2823554C1 |
INHALATION COMPOSITIONS CONTAINING GLYCOPYRRONIUM SALTS | 2007 |
|
RU2453302C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2642624C2 |
PHARMACEUTICAL COMPOSITION FOR INHALATION | 2010 |
|
RU2493833C2 |
NEW DOSE AND FORMULATION | 2009 |
|
RU2608713C2 |
Authors
Dates
2012-12-27—Published
2008-10-23—Filed